BackAB Active ETFs- AB Corporate Bond ETF Overview

AB Active ETFs- AB Corporate Bond ETF Current Cash

AB Active ETFs- AB Corporate Bond ETF's current cash is $11M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$10.96M
190.51% YoYΔ $7.18M vs prior year quarter

Peer average

Loading

AB Active ETFs- AB Corporate Bond ETF Current Cash History

Loading

AB Active ETFs- AB Corporate Bond ETF vs. peers: Current Cash Comparison

Loading

AB Active ETFs- AB Corporate Bond ETF Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

AB Active ETFs- AB Corporate Bond ETF (EYEG) FAQ

The latest current cash for EYEG is $11M as of March 2026. That compares with $3.8M in the prior-year period — up 190.5% year over year. Investors often review this figure alongside AB Active ETFs- AB Corporate Bond ETF's historical trend and sector peers before judging valuation or financial health.

Over the past year, EYEG's current cash moved from $3.8M to $11M — a 190.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in AB Active ETFs- AB Corporate Bond ETF's operating scale or balance-sheet position.

A current cash figure of $11M for EYEG is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting EYEG's current cash ($11M), review year-over-year change from $3.8M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack AB Active ETFs- AB Corporate Bond ETF's current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.